Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Development of VHL-recruiting STING PROTACs that suppress innate immunity

View through CrossRef
Abstract STING acts as a cytosolic nucleotide sensor to trigger host defense upon viral or bacterial infection. While STING hyperactivation can exert anti-tumor effects by increasing T-cell filtrates, in other contexts hyperactivation of STING can contribute to autoimmune and neuroinflammatory diseases. Several STING targeting agonists and a smaller subset of antagonists have been developed, yet STING targeted degraders, or PROTACs, remain underexplored. Here, we report a series of STING-agonist derived PROTACs that promote STING degradation in renal cell carcinoma (RCC) cells. We show that our STING PROTACs activate STING and target activated/phospho-STING for degradation. Locking STING on the endoplasmic reticulum via site-directed mutagenesis disables STING translocation to the proteasome and resultingly blocks STING degradation. We also demonstrate that PROTAC treatment blocks downstream signaling events and attenuates the anti-viral response. Interestingly, we find that VHL acts as a bona fide E3 ligase for STING in RCC; thus, VHL-recruiting STING PROTACs further promote VHL-dependent STING degradation. Our study reveals the design and biological assessment of VHL-recruiting agonist-derived STING PROTACs, as well as demonstrates an example of hijacking a physiological E3 ligase to enhance target protein degradation.
Title: Development of VHL-recruiting STING PROTACs that suppress innate immunity
Description:
Abstract STING acts as a cytosolic nucleotide sensor to trigger host defense upon viral or bacterial infection.
While STING hyperactivation can exert anti-tumor effects by increasing T-cell filtrates, in other contexts hyperactivation of STING can contribute to autoimmune and neuroinflammatory diseases.
Several STING targeting agonists and a smaller subset of antagonists have been developed, yet STING targeted degraders, or PROTACs, remain underexplored.
Here, we report a series of STING-agonist derived PROTACs that promote STING degradation in renal cell carcinoma (RCC) cells.
We show that our STING PROTACs activate STING and target activated/phospho-STING for degradation.
Locking STING on the endoplasmic reticulum via site-directed mutagenesis disables STING translocation to the proteasome and resultingly blocks STING degradation.
We also demonstrate that PROTAC treatment blocks downstream signaling events and attenuates the anti-viral response.
Interestingly, we find that VHL acts as a bona fide E3 ligase for STING in RCC; thus, VHL-recruiting STING PROTACs further promote VHL-dependent STING degradation.
Our study reveals the design and biological assessment of VHL-recruiting agonist-derived STING PROTACs, as well as demonstrates an example of hijacking a physiological E3 ligase to enhance target protein degradation.

Related Results

Rôle de la nouvelle isoforme d’épissage du gène von Hippel-Lindau dans la survenue d’érythrocytoses et de cancers du rein héréditaires
Rôle de la nouvelle isoforme d’épissage du gène von Hippel-Lindau dans la survenue d’érythrocytoses et de cancers du rein héréditaires
La protéine von Hippel-Lindau (VHL), codée par le gène VHL constitué de 3 exons, est un facteur clé de la régulation de la voie de l’hypoxie dont l’acteur majeur est le facteur de ...
EPCO-21. STING PROMOTER EPIGENETIC SILENCING IN GLIOBLASTOMA
EPCO-21. STING PROMOTER EPIGENETIC SILENCING IN GLIOBLASTOMA
Abstract The Stimulator of interferon genes (STING) protein is a critical component of the innate immune response to pathogenic and cytosolic self DNA. The importanc...
VHL ligand binding increases intracellular level of VHL
VHL ligand binding increases intracellular level of VHL
Abstract The von–Hippel Lindau (VHL) protein is a tumour suppressor protein frequently mutated in the VHL disease, which functions as substrate r...
Abstract 919: Endogenous STING inhibition induces breast cancer cell death
Abstract 919: Endogenous STING inhibition induces breast cancer cell death
Abstract Several studies have recently indicated the (re)activation of the immune system against tumor cells as an effective strategy to inhibit tumor growth. A curr...
mRNA PROTACs: engineering PROTACs for high‐efficiency targeted protein degradation
mRNA PROTACs: engineering PROTACs for high‐efficiency targeted protein degradation
AbstractProteolysis‐targeting chimeras (PROTACs) are essential bifunctional molecules that target proteins of interest (POIs) for degradation by cellular ubiquitination machinery. ...
Cytosolic DNA‐STING‐NLRP3 axis is involved in murine acute lung injury induced by lipopolysaccharide
Cytosolic DNA‐STING‐NLRP3 axis is involved in murine acute lung injury induced by lipopolysaccharide
Abstract The role of NOD‐like receptor protein 3 (NLRP3)‐mediated pyroptosis in acute lung injury (ALI) has been well identified previously. Stimulator of interfe...

Back to Top